Collectively, we demonstrated that the co-elevated expression of TDP-43 and HDAC6 positively correlated with the high-grade glioma and GBM, suggesting the TDP-43/HDAC6 could be a potential marker of prognosis in GBM. Here, TARDBP is linked to central nervous system cancer.